English

Kronos Bio, Inc.

EDGAR

KRON Quarterly report (10-Q) · filed 2025-05-08

Annual consolidated revenue for 2024: about USD 9.8M, using the latest reported figures. The previous period, 2023, was about USD 6.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.9 million USD

2025 Q1 · USD

Exact inputs and evidence

Revenue: 1900000 USD Source

Operating margin

-496.95%

2025 Q1 · %

Exact inputs and evidence

Operating Income: -9442000 USD Source
Revenue: 1900000 USD Source

Operating cash flow

-12.8 million USD

2025 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -12842000 USD Source

Free cash flow

-12.8 million USD

2025 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -12842000 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 91.6 million USD 2025-03-31 Source
Exact value

91577000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 61 million shares 2025-03-31 Source
Exact value

60969000 shares

Reported share-count change

1.46% · 880 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

60089000 shares · 2024-03-31· Source
60969000 shares · 2025-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

9.2 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Revenue: 2700000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 2400000 USD · 2024-07-01 – 2024-09-30 Source
Revenue: 9800000 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 7600000 USD · 2024-01-01 – 2024-09-30 Source
Revenue: 1900000 USD · 2025-01-01 – 2025-03-31 Source

Net income

-64.5 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Net income: -16200000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -14108000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -86079000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -60266000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -8364000 USD · 2025-01-01 – 2025-03-31 Source

Operating cash flow

-54.4 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Operating cash flow: -40229000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -23899000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -52600000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -40229000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -65435000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -52600000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -12842000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-08.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2024-12-31
Operating income: 7 of 11 periods available· newest 2024-12-31
Net income: 7 of 11 periods available· newest 2024-12-31
Operating cash flow: 7 of 11 periods available· newest 2024-12-31
Capital expenditure: 7 of 11 periods available· newest 2024-12-31
Total assets: 3 of 11 periods available· newest 2024-12-31
Total liabilities: 3 of 11 periods available· newest 2024-12-31
Current assets: 3 of 11 periods available· newest 2024-12-31
Current liabilities: 3 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+55.6%

Prior period

USD 6.3 million

2023-01-01 – 2023-12-31
Current period

USD 9.8 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

9800000 − 6300000 = 3500000 USD

6300000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
9800000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Year-over-year change in Revenue: 3500000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 9800000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1177489 Filing: 000174183025000009 Input fundies:Revenue: 6300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1177672 Filing: 000174183025000009
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 26.59 million

Prior period

−USD 112.67 million

2023-01-01 – 2023-12-31
Current period

−USD 86.08 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-86079000 − -112673000 = 26594000 USD

-112673000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-86079000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Year-over-year change in Net income: 26594000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -86079000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1388155 Filing: 000174183025000009 Input fundies:NetIncome: -112673000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1388996 Filing: 000174183025000009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 13.15 million

Prior period

−USD 78.58 million

2023-01-01 – 2023-12-31
Current period

−USD 65.44 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-65435000 − -78582000 = 13147000 USD

-78582000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-65435000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Year-over-year change in Operating cash flow: 13147000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -65435000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931022 Filing: 000174183025000009 Input fundies:OperatingCashFlow: -78582000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931669 Filing: 000174183025000009
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-99.4%

Prior period

USD 679,000

2023-01-01 – 2023-12-31
Current period

USD 4,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

4000 − 679000 = -675000 USD

679000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
4000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Year-over-year change in Capital expenditure: -675000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#932959 Filing: 000174183025000009 Input fundies:CapitalExpenditure: 679000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#933511 Filing: 000174183025000009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 9.8 million 100% of revenue
Operating costs Derived USD 102.69 million 1,048% of revenue
Operating income −USD 92.89 million −948% of revenue
Tax, interest and other Derived −USD 6.81 million −69% of revenue
Net income −USD 86.08 million −878% of revenue

Cash

Operating cash flow −USD 65.44 million −668% of revenue
Capital expenditure USD 4,000 0% of revenue
Free cash flow Derived −USD 65.44 million −668% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2022 Not shown: operating income or net income is not reported.
2023 Operating loss: operating costs were 2,038% of revenue.
2024 Operating loss: operating costs were 1,048% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2022 2022-01-01 – 2022-12-31	0	137115000 Derived	-137115000	-3911000 Derived	-133204000	-91503000 Derived	Source 2022-01-01 – 2022-12-31: 0 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -137115000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -133204000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -90926000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 577000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	6300000	128377000 Derived	-122077000	-9404000 Derived	-112673000	-79261000 Derived	Source 2023-01-01 – 2023-12-31: 6300000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -122077000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -112673000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -78582000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 679000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	9800000	102687000 Derived	-92887000	-6808000 Derived	-86079000	-65439000 Derived	Source 2024-01-01 – 2024-12-31: 9800000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -92887000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -86079000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -65435000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 4000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 9.8M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Revenue	0	Revenue: 0 Open source
20232023-12-31	Revenue	6300000	Revenue: 6300000 Open source
20242024-12-31	Revenue	9800000	Revenue: 9800000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

55.6% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 6300000 Open source Revenue: 0 Open source
20242024-12-31	Year over year	55.6%	Revenue: 9800000 Open source Revenue: 6300000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -947.8% 2024

Net margin -878.4% 2024

Free cash flow margin -667.7% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Operating margin	Not reported	Operating Income: -137115000 Open source Revenue: 0 Open source
20232023-12-31	Operating margin	-1,937.7%	Operating Income: -122077000 Open source Revenue: 6300000 Open source
20242024-12-31	Operating margin	-947.8%	Operating Income: -92887000 Open source Revenue: 9800000 Open source
20222022-12-31	Net margin	Not reported	Net Income: -133204000 Open source Revenue: 0 Open source
20232023-12-31	Net margin	-1,788.5%	Net Income: -112673000 Open source Revenue: 6300000 Open source
20242024-12-31	Net margin	-878.4%	Net Income: -86079000 Open source Revenue: 9800000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -90926000 Open source Capital Expenditure: 577000 Open source
20232023-12-31	Free cash flow margin	-1,258.1%	Revenue: 6300000 Open source Operating Cash Flow: -78582000 Open source Capital Expenditure: 679000 Open source
20242024-12-31	Free cash flow margin	-667.7%	Revenue: 9800000 Open source Operating Cash Flow: -65435000 Open source Capital Expenditure: 4000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -65.4M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Operating cash flow	-90926000	Operating Cash Flow: -90926000 Open source
20232023-12-31	Operating cash flow	-78582000	Operating Cash Flow: -78582000 Open source
20242024-12-31	Operating cash flow	-65435000	Operating Cash Flow: -65435000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -65.4M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20222022-12-31	Free cash flow	-91503000	Operating Cash Flow: -90926000 Open source Capital Expenditure: 577000 Open source
20232023-12-31	Free cash flow	-79261000	Operating Cash Flow: -78582000 Open source Capital Expenditure: 679000 Open source
20242024-12-31	Free cash flow	-65439000	Operating Cash Flow: -65435000 Open source Capital Expenditure: 4000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

29.6% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Liabilities / assets	17.1%	Total Liabilities: 50439000 Open source Total Assets: 294938000 Open source
20232023-12-31	Liabilities / assets	25.4%	Total Liabilities: 54201000 Open source Total Assets: 213279000 Open source
20242024-12-31	Liabilities / assets	29.6%	Total Liabilities: 36783000 Open source Total Assets: 124363000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.54× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20222022-12-31	Current assets / current liabilities	11.37×	Current Assets: 244291000 Open source Current Liabilities: 21486000 Open source
20232023-12-31	Current assets / current liabilities	7.24×	Current Assets: 178778000 Open source Current Liabilities: 24695000 Open source
20242024-12-31	Current assets / current liabilities	7.54×	Current Assets: 115228000 Open source Current Liabilities: 15277000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 6.72 million Exact value Exact value: -6721000 USD 2018-01-01 – 2018-12-31: -6721000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2018-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -6721000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6721000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183021000018/kron-20201231.htm#2060548 Filing: 000174183021000018 The citation records this snapshot. The page link may show a newer release later.	−USD 6.44 million Exact value Exact value: -6441000 USD 2018-01-01 – 2018-12-31: -6441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2018-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -6441000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6441000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183021000018/kron-20201231.htm#1365792 Filing: 000174183021000018 The citation records this snapshot. The page link may show a newer release later.	USD 1.08 million Exact value Exact value: 1075000 USD 2018-01-01 – 2018-12-31: 1075000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2018-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 1075000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1075000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183021000018/kron-20201231.htm#1370065 Filing: 000174183021000018 The citation records this snapshot. The page link may show a newer release later.	−USD 7.52 million Calculation and evidence -6441000 − 1075000 USD Exact free cash flow: -7516000 USD 2018-01-01 – 2018-12-31: -6441000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1075000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2018-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -7516000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6441000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183021000018/kron-20201231.htm#1365792 Filing: 000174183021000018 Input fundies:CapitalExpenditure: 1075000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183021000018/kron-20201231.htm#1370065 Filing: 000174183021000018 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 16.12 million Exact value Exact value: -16117000 USD 2019-01-01 – 2019-12-31: -16117000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2019-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -16117000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16117000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#2085270 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	−USD 15.08 million Exact value Exact value: -15082000 USD 2019-01-01 – 2019-12-31: -15082000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2019-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -15082000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15082000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1384700 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Exact value Exact value: 2948000 USD 2019-01-01 – 2019-12-31: 2948000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2019-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 2948000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2948000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1388992 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	−USD 18.03 million Calculation and evidence -15082000 − 2948000 USD Exact free cash flow: -18030000 USD 2019-01-01 – 2019-12-31: -15082000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2948000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2019-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -18030000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15082000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1384700 Filing: 000174183022000006 Input fundies:CapitalExpenditure: 2948000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1388992 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 88.44 million Exact value Exact value: -88444000 USD 2020-01-01 – 2020-12-31: -88444000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2020-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -88444000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88444000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#2084114 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	−USD 37.91 million Exact value Exact value: -37912000 USD 2020-01-01 – 2020-12-31: -37912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2020-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -37912000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37912000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1383661 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	USD 9.57 million Exact value Exact value: 9568000 USD 2020-01-01 – 2020-12-31: 9568000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2020-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 9568000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9568000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1388015 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.	−USD 47.48 million Calculation and evidence -37912000 − 9568000 USD Exact free cash flow: -47480000 USD 2020-01-01 – 2020-12-31: -37912000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 9568000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2020-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -47480000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37912000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1383661 Filing: 000174183022000006 Input fundies:CapitalExpenditure: 9568000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183022000006/kron-20211231.htm#1388015 Filing: 000174183022000006 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 151.08 million Exact value Exact value: -151078000 USD 2021-01-01 – 2021-12-31: -151078000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2021-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -151078000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -151078000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183023000011/kron-20221231.htm#1571941 Filing: 000174183023000011 The citation records this snapshot. The page link may show a newer release later.	−USD 117.92 million Exact value Exact value: -117924000 USD 2021-01-01 – 2021-12-31: -117924000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2021-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -117924000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -117924000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183023000011/kron-20221231.htm#1131095 Filing: 000174183023000011 The citation records this snapshot. The page link may show a newer release later.	USD 4.26 million Exact value Exact value: 4260000 USD 2021-01-01 – 2021-12-31: 4260000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2021-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 4260000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4260000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183023000011/kron-20221231.htm#1133410 Filing: 000174183023000011 The citation records this snapshot. The page link may show a newer release later.	−USD 122.18 million Calculation and evidence -117924000 − 4260000 USD Exact free cash flow: -122184000 USD 2021-01-01 – 2021-12-31: -117924000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 4260000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2021-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -122184000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -117924000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183023000011/kron-20221231.htm#1131095 Filing: 000174183023000011 Input fundies:CapitalExpenditure: 4260000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183023000011/kron-20221231.htm#1133410 Filing: 000174183023000011 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 133.2 million Exact value Exact value: -133204000 USD 2022-01-01 – 2022-12-31: -133204000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2022-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -133204000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -133204000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183024000021/kron-20231231.htm#1567774 Filing: 000174183024000021 The citation records this snapshot. The page link may show a newer release later.	−USD 90.93 million Exact value Exact value: -90926000 USD 2022-01-01 – 2022-12-31: -90926000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2022-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -90926000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -90926000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183024000021/kron-20231231.htm#1091312 Filing: 000174183024000021 The citation records this snapshot. The page link may show a newer release later.	USD 577,000 Exact value Exact value: 577000 USD 2022-01-01 – 2022-12-31: 577000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2022-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 577000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 577000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183024000021/kron-20231231.htm#1093152 Filing: 000174183024000021 The citation records this snapshot. The page link may show a newer release later.	−USD 91.5 million Calculation and evidence -90926000 − 577000 USD Exact free cash flow: -91503000 USD 2022-01-01 – 2022-12-31: -90926000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 577000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2022-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -91503000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -90926000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183024000021/kron-20231231.htm#1091312 Filing: 000174183024000021 Input fundies:CapitalExpenditure: 577000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183024000021/kron-20231231.htm#1093152 Filing: 000174183024000021 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 112.67 million Exact value Exact value: -112673000 USD 2023-01-01 – 2023-12-31: -112673000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2023-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -112673000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -112673000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1388996 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	−USD 78.58 million Exact value Exact value: -78582000 USD 2023-01-01 – 2023-12-31: -78582000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2023-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -78582000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -78582000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931669 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	USD 679,000 Exact value Exact value: 679000 USD 2023-01-01 – 2023-12-31: 679000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2023-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 679000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 679000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#933511 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	−USD 79.26 million Calculation and evidence -78582000 − 679000 USD Exact free cash flow: -79261000 USD 2023-01-01 – 2023-12-31: -78582000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 679000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2023-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -79261000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -78582000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931669 Filing: 000174183025000009 Input fundies:CapitalExpenditure: 679000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#933511 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 86.08 million Exact value Exact value: -86079000 USD 2024-01-01 – 2024-12-31: -86079000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Net Income: -86079000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -86079000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#1388155 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	−USD 65.44 million Exact value Exact value: -65435000 USD 2024-01-01 – 2024-12-31: -65435000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Operating Cash Flow: -65435000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65435000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931022 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	USD 4,000 Exact value Exact value: 4000 USD 2024-01-01 – 2024-12-31: 4000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Capital Expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#932959 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.	−USD 65.44 million Calculation and evidence -65435000 − 4000 USD Exact free cash flow: -65439000 USD 2024-01-01 – 2024-12-31: -65435000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 4000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kronos Bio, Inc. · 2024-12-31 Kronos Bio, Inc. (edgar:1741830) Free cash flow: -65439000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T08:39:40Z Snapshot: 3510c24dde734813a5e647c18dde820fbaf794dbd38d2c70df64af7189235352 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1741830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -65435000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#931022 Filing: 000174183025000009 Input fundies:CapitalExpenditure: 4000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1741830/000174183025000009/kron-20241231.htm#932959 Filing: 000174183025000009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

26 filings · 1,338 latest values · 1,338 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001741830, 1741830, KRON, edgar:1741830

Also known as Kronos Bio, Inc.

Kronos Bio, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation